表紙:マルチストレイン・プロバイオティクスの世界市場-2023年~2030年
市場調査レポート
商品コード
1359943

マルチストレイン・プロバイオティクスの世界市場-2023年~2030年

Global Multistrain Probiotics Market - 2023-2030

出版日: | 発行: DataM Intelligence | ページ情報: 英文 186 Pages | 納期: 約2営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=151.66円
マルチストレイン・プロバイオティクスの世界市場-2023年~2030年
出版日: 2023年10月11日
発行: DataM Intelligence
ページ情報: 英文 186 Pages
納期: 約2営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

概要:

マルチストレイン・プロバイオティクスの世界市場は、2022年に730億米ドルに達し、2023-2030年の予測期間中にCAGR 8.2%で成長し、2030年には1,371億米ドルに達すると予測されています。

マルチストレイン・プロバイオティクスには複数の細菌株が存在します。定期的に摂取することで、腸内環境を健康な状態に保つことができます。プロバイオティクスは、病気や感染因子に対する治療および保護バリアを提供する安全な製品であるため、マルチストレイン・プロバイオティクスの使用は人気が高まっています。様々な分離株間の相乗効果や相加効果により、マルチストレイン・プロバイオティクスはシングルストレイン・プロバイオティクスよりも著しく健康的でもあります。

マルチストレイン・プロバイオティクスは、より広範な効能と相乗効果を示唆するため、今後数年間も市場の勢いは衰えないと思われます。さらに、免疫力、消化器系、健康全般への影響に関する知識の高まりから、マルチストレイン・プロバイオティクスのニーズが高まっています。大手プロバイオティクス・メーカーは、消費者の可処分所得の増加や食生活に対する意識の高まりを利用し、幅広い種類のマルチストレイン・プロバイオティクスの販売収益性の向上に取り組んでいます。

2022年のマルチストレイン・プロバイオティクスの世界市場は、アジア太平洋地域が46.5%の売上シェアで支配的でした。アジア太平洋地域のマルチストレイン・プロバイオティクス市場は、消費者の需要の高まり、メディアの注目、新技術への認識によって牽引されています。中国とインドにおけるプロバイオティクス意識の高まりは、この地域市場の成長を加速させると予想されます。

ダイナミクス:

健康に対する意識の高まり

腸の健康に対する消費者の意識が高まるにつれて、マルチストレイン・プロバイオティクスの需要は増加すると予想されます。健康な腸を維持することが消費者にとってより重要になるにつれ、大手企業は近年、プロバイオティクス食品、飲料、サプリメントを積極的に提供しています。腸の健康と身体の健康、体重管理、エネルギー維持との関連性を受け入れる消費者が増えるにつれて、プロバイオティクスの需要は今後数年間で増加すると予想されます。メーカーによる特定の健康強調表示を伴う食品の生産と販売は、より健康的な食生活を求める傾向の高まりと、栄養が健康に与える影響に対する意識の高まりに促されています。消費者が健康的な生活への全体的なアプローチを採用している欧米市場では、プロバイオティクスの消費が増加しています。

消費者に高品質のプロバイオティクス製品を提供するため、メーカーは免疫効果を付加したプロバイオティクスの処方や製造に試行錯誤しています。複数菌株配合、菌株特異的配合などの研究が行われています。例えば、プロバイオティクス飲料・サプリメント会社のグッドベリープロバイオティクス社は、2022年8月にクォート飲料とショットを含む新しいイミューンサポート製品ラインを発表しました。パイナップル味、パッションフルーツ味、レモン味、ジンジャー味、ターメリック味のグッドベリーイミューンサポートショットには、クォート飲料と同じプロバイオティクス菌株が含まれています。

プロバイオティクス製品の研究開発における国際機関の関与

マルチストレイン・プロバイオティクスの人間および動物に対する健康上の利点は、世界規模で認められています。WHO、IPA、国際プロバイオティクス・プレバイオティクス科学協会などの国際機関は、プロバイオティクスの利点の増大により、プロバイオティクスに対する認識を高めています。プロバイオティクスの研究開発に関する規制と投資政策は、各国政府と協力して協会が立案しており、これがマルチストレイン・プロバイオティクス市場を牽引しています。さらに、プロバイオティクスの調査も大幅に進歩し、様々な菌株の働きや潜在的な健康上の利点についての理解が深まっています。プロバイオティクス業界は、科学の進歩を利用して特定の特徴や能力を持つ菌株を作り出すことにますます関心を寄せています。

新しいプロバイオティクス菌株を開発するための高い研究開発費

マルチストレイン・プロバイオティクス市場の開拓は、研究開発活動、研究所、研究設備への多額の投資、有能な従業員の雇用にかかる高コストによって妨げられています。プロバイオティクス菌株や製品の開発・生産には国際的な食品規制が適用されます。生産コストが高いため、完成品の価格は高いです。プロバイオティクス製品のマーケティングと流通には、さまざまな流通経路が利用されます。パッケージも様々です。このように、これらの要因が製品のコストを上昇させ、より高価なものとし、ひいては消費者の購買行動を抑制し、業界関係者に課題を突きつけています。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • 健康に対する意識の高まり
      • プロバイオティクス製品の研究開発における国際機関の関与
    • 抑制要因
      • 新しいプロバイオティクス株を開発するための高い研究開発費
    • 機会
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格分析
  • 規制分析
  • ロシア・ウクライナ戦争の影響分析
  • DMIの見解

第6章 COVID-19分析

第7章 用途別

  • 食品・飲料
  • 動物飼料
  • 栄養補助食品

第8章 エンドユーザー別

  • ヒト
  • 動物

第9章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋
  • 中東・アフリカ

第10章 競合情勢

  • 競合シナリオ
  • 市況/シェア分析
  • M&A分析

第11章 企業プロファイル

  • Yakult Honsha Co., Ltd.
    • 企業概要
    • 製品ポートフォリオと内容
    • 財務概要
    • 主な動向
  • Deerland Enzymes, Inc.
  • Protexin
  • Danisco
  • BioGaia
  • Chr. Hansen
  • Daflorn Ltd.
  • Lallemand Inc.
  • Probi AB
  • Innovix Labs (LIST NOT EXHAUSTIVE)

第12章 付録

目次
Product Code: FB6995

Overview:

Global Multistrain Probiotics Market reached US$ 73 billion in 2022 and is expected to reach US$ 137.1 billion by 2030, growing with a CAGR of 8.2% during the forecast period 2023-2030.

Multiple bacterial strains are present in multistrain probiotics. Regular consumption keeps the gut in a healthy state. Because it is a safe product that provides a therapeutic and protective barrier against diseases and infectious agents, the use of multistrain probiotics is growing in popularity. Due to the synergy and additive effects between the various isolates, multistrain probiotics are also significantly healthier than single-strain probiotics.

The market for multistrain probiotics is likely to maintain its momentum in the coming years because they suggest a wider spectrum of efficacy and synergistic effects. In addition, there is a rising need for multistrain probiotics due to growing knowledge about their effects on immunity, the digestive system, and overall wellness. Leading probiotics manufacturers are working to increase the profitability of sales of their wide range of multistrain probiotics by taking advantage of consumers' rising disposable income and increasing dietary awareness.

Asia Pacific dominated the global multistrain probiotics market with revenue share of 46.5% in the year 2022. The Asia-Pacific multistrain probiotics market is driven by rising consumer demand, media attention, and awareness of new technology. Growing probiotic awareness in China and India is anticipated to accelerate the growth of the regional market.

Dynamics:

Increasing Awareness About Health

The demand for multistrain probiotics is anticipated to increase as consumer awareness of gut health increases. As maintaining a healthy gut becomes more crucial to consumers, major players have actively offered probiotic food, drinks, and supplements in recent years. Probiotic demand is anticipated to rise in the coming years as more consumers accept the connection between gut health and physical health, weight management, and energy maintenance. The production and marketing of food with specific health claims by manufacturers is prompted by rising trends towards healthier diets and growing awareness of the impact of nutrition on health. Western markets, where consumers adopt a holistic approach to healthy living, are seeing an increase in probiotic consumption.

To provide consumers with high-quality probiotic products, manufacturers are experimenting with the formulation and production of probiotics with the added immunity benefits. Work is being done on multi-strain formulations, strain-specific formations, etc. For instance, the probiotic beverage and supplement company GoodBellyProbiotics unveiled its new Immune Support product line in August 2022, which includes quart beverages and shots. The pineapple, passionfruit, lemon, ginger, and turmeric flavours of the GoodBellyImmune Support Shots contain the same probiotic strains that the quarts do.

International Organisations' Involvement in Probiotic Products Research and Development

The health advantages of multistrain probiotics for both humans and animals are acknowledged on a global scale. International organisations like the WHO, IPA, and the International Scientific Association for Probiotics and Prebiotics are raising awareness about probiotics due to their growing benefits. The regulation and investment policies for probiotic R&D are drafted by associations in collaboration with national governments, which in turn drives the multistrain probiotics market. Additionally, there have been significant advancements in probiotic research, which have improved the understanding of the workings of various strains and their potential health advantages. The probiotic industry is increasingly interested in using scientific advancements to create strains with particular characteristics and capabilities.

High R&D Costs for Developing New Probiotic Strains

The development of the multistrain probiotics market is hindered by significant investments in R&D activities, laboratories, research equipment, and the high cost of hiring qualified employees. International food regulations are followed in the development and production of probiotic strains and products. Due to the high cost of production, the price of the finished product is high. Different channels of distribution are used for marketing and distributing probiotic products. They come in various packaging as well. Thus, these factors raise the cost of the product, making it more expensive, which in turn restrains consumer purchasing behaviour and presents a challenge for industry players.

Segment Analysis:

The global multistrain probiotics market is segmented based on application, end-user and region.

Enzymes and Probiotics are Being Added to Food and Beverage Products by Manufacturers More Frequently

The segment is anticipated to grow as a result of rising consumer demand for food products with higher nutrient and fibre contents. Probiotics and other digestive ingredients are frequently used in fish oil and yoghurt to lower the risk of issues with gut health. Probiotics have become more popular among consumers as a remedy for their health problems as a result of rising disposable incomes and a growing awareness of ways to improve quality of life. Due to the rising demand for probiotics in foods and drinks, manufacturers are growing their operations. For instance, Korea's Hy Co, formerly known as Korea Yakult, announced in August 2022 that it would be expanding into probiotic business categories to offer a wider range of products.

Geographical Penetration:

In Asia Pacific, Disposable Incomes are Rising, Standards of Living are Rising, and Acceptance of Functional Foods is Growing

Due to growing awareness of fitness and maintaining good digestive health, consumers in this region are becoming more and more interested in healthy products. In addition, there is a growing market for products that support a healthy gut microbiome due to the growing significance of gut health in overall wellbeing. Multistrain probiotic supplements are becoming more and more well-liked among the region's health-conscious consumers because they are thought to be an easy and efficient way to add beneficial bacteria to the gut. The demand for multistrain probiotics in infant formula has been extremely high in China and is expected to continue to rise over the next few years. Due to an ageing population, a growing awareness of the value of preventive healthcare, and numerous studies demonstrating the advantages of these products for immunity, cognitive health, and skincare, the market in Asia Pacific has experienced significant growth.

COVID-19 Impact Analysis:

The COVID-19 pandemic has increased understanding of the value of a robust immune system. To support their immune systems, many consumers have turned to dietary supplements, such as multistrain probiotics. The marketing of some multistrain probiotics as immune-boosters has increased demand. Furthermore, the significance of overall health and wellness has been emphasised by COVID-19. Customers are more likely to spend money on products that support overall health, which includes gut health. Multistrain probiotics have benefited from this development because of their potential to support immune and digestive health.

Russia-Ukraine War Impact Analysis:

Supply chains were disrupted by geopolitical tensions and economic sanctions, which had an impact on where raw materials were sourced and how multistrain probiotics were produced. Supply issues result from suppliers or manufacturers being situated in regions that are directly impacted by the conflict. Additionally, the economic unpredictability brought on by the war caused some consumers to cut back on discretionary spending, including on dietary supplements. The sales of multistrain probiotics were impacted by this.

By Application

  • Food and Beverages
  • Animal Feed
  • Dietary Supplements

By End-User

  • Humans
  • Animals

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa

Key Developments

  • In March 2023, The FX-856 strain, which lessens the symptoms of diarrhoea, constipation, bloating, and ulcerative colitis, was introduced by the English pharmaceutical company FERRYX Ltd.
  • In May 2023, Roquette unveiled PEARLITOL ProTec, a cutting-edge excipient made with the intention of improving the stability of probiotic supplements.
  • In April 2023, an improved quality specification for the well-known probiotic bacteria LifeinU L. Rhamnosus GG was introduced by Lesaffre's Gnosis.

Competitive Landscape

The major global players in the market: Yakult Honsha Co., Ltd., Deerland Enzymes, Inc., Protexin, Danisco, BioGaia, Chr. Hansen, Daflorn Ltd., Lallemand Inc., Probi AB and Innovix Labs.

Why Purchase the Report?

  • To visualize the global multistrain probiotics market segmentation based on application, end-user, and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of multistrain probiotics market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global multistrain probiotics market report would provide approximately 53 tables, 46 figures and 186 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Application
  • 3.2. Snippet by End-User
  • 3.3. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing Awareness About Health
      • 4.1.1.2. International Organisations' Involvement in Probiotic Products Research and Development
    • 4.1.2. Restraints
      • 4.1.2.1. High R&D Costs for Developing New Probiotic Strains
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Russia-Ukraine War Impact Analysis
  • 5.6. DMI Opinion

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID
    • 6.1.2. Scenario During COVID
    • 6.1.3. Scenario Post COVID
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Application

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 7.1.2. Market Attractiveness Index, By Application
  • 7.2. Food and Beverages*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Animal Feed
  • 7.4. Dietary Supplements

8. By End-User

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.1.2. Market Attractiveness Index, By End-User
  • 8.2. Humans*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Animal

9. By Region

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.5.1. U.S.
      • 9.2.5.2. Canada
      • 9.2.5.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.5.1. Germany
      • 9.3.5.2. UK
      • 9.3.5.3. France
      • 9.3.5.4. Italy
      • 9.3.5.5. Spain
      • 9.3.5.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.5.1. Brazil
      • 9.4.5.2. Argentina
      • 9.4.5.3. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.5.1. China
      • 9.5.5.2. India
      • 9.5.5.3. Japan
      • 9.5.5.4. Australia
      • 9.5.5.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

10. Competitive Landscape

  • 10.1. Competitive Scenario
  • 10.2. Market Positioning/Share Analysis
  • 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

    • 11.1.1. Yakult Honsha Co., Ltd.*
    • 11.1.2. Company Overview
    • 11.1.3. Product Portfolio and Description
    • 11.1.4. Financial Overview
    • 11.1.5. Key Developments
  • 11.2. Deerland Enzymes, Inc.
  • 11.3. Protexin
  • 11.4. Danisco
  • 11.5. BioGaia
  • 11.6. Chr. Hansen
  • 11.7. Daflorn Ltd.
  • 11.8. Lallemand Inc.
  • 11.9. Probi AB
  • 11.10. Innovix Labs LIST NOT EXHAUSTIVE

12. Appendix

  • 12.1. About Us and Services
  • 12.2. Contact Us